EDNA LONDON: Open Payments
NPI 1578074910 · BRENTWOOD, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,210 in 65 payments from 26 companies in 2025. Trend: 2023 $1,427 · 2024 $1,765 · 2025 $2,210
Food & beverage: $1,230Long term medical supply or device loan: $981
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 17 | $1,152 |
| GENZYME CORPORATION | 4 | $109 |
| AstraZeneca Pharmaceuticals LP | 4 | $94 |
| Incyte Corporation | 3 | $82 |
| PFIZER INC. | 4 | $76 |
| Daiichi Sankyo Inc. | 3 | $75 |
| Celgene Corporation | 3 | $54 |
| Genentech USA, Inc. | 3 | $53 |
| Alexion Pharmaceuticals, Inc. | 2 | $51 |
| Gilead Sciences, Inc. | 2 | $46 |
Products named: KISQALI, Fabhalta, REBLOZYL, JAKAFI, ULTOMIRIS, Enhertu, Trodelvy, CABLIVI.
Industry payments across TN — which companies pay providers there.
